Profil bibliographique

Dhruva Biswas

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

117Publications signalées

6188Citations signalées

9Affiliations récentes

Institutions déclarées

The Francis Crick Institute Cancer Research UK British Heart Foundation Yale University London Cancer CRUK Lung Cancer Centre of Excellence Sarnoff Cardiovascular Research Foundation University College London Yara (Norway)

Domaines associés

Cancer Genomics and DiagnosticsCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsRNA modifications and cancerHeart Failure Treatment and Management

Publications récentes

Accès ouvert 2026 articleOpenAlex

Development and multinational validation of artificial intelligence-enabled ASCVD risk stratification using electrocardiograms

Bruno Batinica, Evangelos K Oikonomou, Aline F Pedroso, Arya Aminorroaya et autres

1 citationAmerican Journal of Preventive Cardiology

Accès ouvert 2026 articleOpenAlex

Refining Stratification in Premenopausal Node-Positive HR+/HER2− Breast Cancer With a Novel AI-Based Test

Jailan Elayoubi, Cerise Tang, Kathryn J. Ruddy, Khalil Choucair et autres

0 citationsClinical Breast Cancer

Accès ouvert 2026 preprintOpenAlex

Prognostic performance of an AI-based recurrence risk model in clinically low-risk HR+/HER2- early breast cancer

Cerise Tang, Dhruva Biswas, Chuwen Liu, Ken Zeng et autres

0 citationsmedRxiv

Accès ouvert 2026 conference-abstractOpenAlex

Real-world deployment of a multimodal artificial intelligence (AI) model for predicting response to neoadjuvant chemotherapy in early breast cancer.

Bareket Daniel, Michèle Buchinger, Dhruva Biswas, Jungkyu Park et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstractOpenAlex

Evaluating the prognostic performance of an AI-based model in clinically low-risk HR+/HER2− early breast cancer.

Dhruva Biswas, Cerise Tang, Ken Zeng, Krzysztof J. Geras et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstractOpenAlex

Estimating individual benefit from adjuvant chemotherapy in hormone receptor–positive breast cancer using causal multimodal artificial intelligence.

Frederick Howard, Jad M. Abdelsattar, Dhruva Biswas, Jeroen Berrevoets et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2026 conference-abstractOpenAlex

Evaluating performance of an AI-based recurrence score in early breast cancer patients treated with chemoendocrine therapy: A secondary analysis of the UNIRAD trial.

Thomas Bachelot, Sylvie Chabaud, Jerome Lemonnier, Paul Cottu et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2026 articleOpenAlex